Immunization is one of the greatest public health achievements of the past century. Vaccines are responsible for the worldwide eradication of smallpox, the elimination of polio in the western hemisphere, and most recently the elimination of rubella as a public health threat in the United States. Childhood vaccination rates are at an all-time high, but immunization falls off dramatically during adolescence (ages 11–19). With increased attention being paid to adolescent health and the new vaccines available for adolescents, efforts to increase adolescent immunization rates are moving to the forefront. Improving adolescent immunization rates requires advocacy on the part of all health professionals. School nurses, whose mission is to enhance the well-being of adolescents, are in a unique position to work with students, parents, and local health professionals to improve the adolescent immunization rate.
American Academy of Pediatrics (AAP). (1997). Immunization of adolescents: Recommendations of the Advisory Committee on Immunization Practices, the American Academy of Pediatrics, the American Academy of Family Physicians, and the American Medical Association.Pediatrics, 99, 479–488.
Centers for Disease Control and Prevention (CDC). (1999). Ten great public health achievements—United States, 1990–1999.MMWR Morbidity and Mortality Weekly Report, 48, 241–248.
4.
Centers for Disease Control and Prevention (CDC). (2003). Decline in annual incidence of varicella—Selected states, 1990–2001.MMWR Morbidity and Mortality Weekly Report, 52, 884–885.
5.
Centers for Disease Control and Prevention (CDC). (2004a). Summary of notifiable diseases—United States, 2002.MMWR Morbidity and Mortality Weekly Report, 51, 1–84.
6.
Centers for Disease Control and Prevention (CDC). (2004b). Vaccination coverage among children entering school—United States, 2003–04 school yearMMWR Morbidity and Mortality Weekly Report, 54, 1041–1044.
7.
Centers for Disease Control and Prevention (CDC). (2004c). Deaths: Final data for 2002.National Vital Statistics Report, 53, 29.
8.
Centers for Disease Control and Prevention (CDC). (2004d). Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP).MMWR Morbidity and Mortality Weekly Report, 53(RR-6), 1–40.
9.
Centers for Disease Control and Prevention (CDC). (2005a). Elimination of rubella and congenital rubella syndrome—United States, 1969–2004.MMWR Morbidity and Mortality Weekly Report, 54(early release), 1–4.
Centers for Disease Control and Prevention (CDC). (2005c). Meningococcal conjugate vaccine: Meningococcal (groups A, C, Y, and W-135) conjugate vaccine (MCV-4).ACIP recommends meningococcal vaccine for adolescents and college freshmen. Retrieved March 4, 2005, from http://www.cdc.gov/nip/vaccine/meningitis/mcv4/mcv4acip.htmacip.htm
12.
Centers for Disease Control and Prevention (CDC). (2005d). Recommended childhood and adolescent immunization schedule—United States, 2005.MMWR Morbidity and Mortality Weekly Report, 3, Q-1–Q-3.
13.
Centers for Disease Control and Prevention (CDC). (2005e). Summary of Notifiable Diseases—United States, 2003.MMWR Morbidity and Mortality Weekly Report, 54(15), 389–399.
14.
Centers for Disease Control and Prevention (CDC). (n.d.). National immunization program's strategic plan for 2000–2005. Retrieved May 4, 2005, from http://www.cdc.gov/nip/webutil/about/default/htm
15.
DavisM. M., PatelM. S., & GebremariamA. (2004). Decline in varicella-related hospitalizations and expenditures for children and adults after introduction of varicella vaccine in the United States.Pediatrics, 114, 786–792.
16.
EricksonL., & De WalsP. (1998). Complications and sequelae of meningococcal disease in Quebec, Canada, 1990–1994.Clinical Infectious Disease, 26, 1159–1164.
17.
EricksonL. J., De WalsP., McMahonJ., & HeimS. (2001). Complications of meningococcal disease in college students.Clinical Infectious Disease, 33, 737–739.
National Association of School Nurses (NASN). (2003, August 22). Press release: Many teens and adults lack protection against tetanus and diphtheria (TD), other vaccine preventable diseases. Retrieved May 5, 2005, from http://nasn.org/releases/03vaccine.htm
21.
National Committee for Quality Assurance (NCQA). (2004). The state of health care quality: 2004. Retrieved May 5, 2005, from http://www.ncqa.org
22.
NguyenH. Q., JumaanA. O., SewardJ. F. (2005). Decline in mortality due to varicella after implementation of varicella vaccination in the United States.New England Journal of Medicine, 352, 450–458.
23.
SandersG. D., & TairaA. V. (2003). Cost-effectiveness of a potential vaccine for human papillomavirus.Emerging Infectious Diseases, 9(1), 37–48.
24.
ShaikR., GurisD., StrebelP., & WhartonM. (1998). Underreporting of pertussis deaths in the United States: Need for improved surveillance.Pediatrics, 323, 101–102.
25.
SutterR. W., & CochiS. L. (1992). Pertussis hospitalizations and mortality in the United States, 1985–1988. Evaluation of the completeness of national reporting.Journal of the American Medical Association, 267, 386–391.
U.S. Department of Health and Human Services (USDHHS). (n.d.). Report on carcinogens, eleventh edition. Retrieved May 5, 2005, from http://ntp.niehs.nih.gov/ntp/roc/tocll.html
28.
U.S. Department of Health and Human Services (USDHHS). (2000). Healthy People 2010. Retrieved from http://www.healthypeople.gov
29.
U.S. Food and Drug Administration (USFDA). (2005, June 10). FDA approves a new combination vaccine to help protect both adolescents and adults against whooping cough.FDA talk paper. Retrieved November 30, 2005, from http://fda.gov/bbs/topics/ANSWERS/ANS01361.html
30.
WatsonB. (2001). A review of varicella vaccine.Pediatric Annals, 30, 362–367.
31.
WeyckerD., EdelsbergJ., HalloranM. E., LonginiI. M., NizamA., CiurylaV., & OsterG. (2005). Population-wide benefits of routine vaccination of children against influenza.Vaccine, 23, 1284–1293.
